Atlas Trials

Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer

Clinical trial NCT02008994 · TERMINATED

Trial details

NCT number
NCT02008994
Sponsor
Sanford Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-09-01
Primary completion
2014-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.